Skip to main content

Rosetta Biosoftware, Agilent Technologies, Galapagos Genomics, Incyte


Rosetta Biosoftware and Agilent Technologies last week introduced the Rosetta Luminator system version 2.0, a system for storing and analyzing microarray data. Developed by Rosetta Biosoftware and distributed by Agilent, the system includes ANOVA (analysis of variance); Bayesian Classifiers; and PCA (principal components analysis). It is built on an Oracle database and is positioned as an “affordable” enterprise solution for small- to mid-sized organizations.


Galapagos Genomics of Mechelen, Belgium, last week introduced FleXSelect, a human full-length gene adenoviral expression library, developed in collaboration with Incyte. The system contains over 1,200 fully sequence-verified and largely unannotated human genes to use in gene-function discovery.


The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.